X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Patent (330) 330
Journal Article (213) 213
Publication (5) 5
Book Chapter (4) 4
Book / eBook (2) 2
Book Review (2) 2
Conference Proceeding (1) 1
Dissertation (1) 1
Newspaper Article (1) 1
Reference (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
chemistry (334) 334
organic chemistry (330) 330
metallurgy (326) 326
human necessities (249) 249
hygiene (249) 249
medical or veterinary science (249) 249
preparations for medical, dental, or toilet purposes (234) 234
heterocyclic compounds (172) 172
peptides (162) 162
specific therapeutic activity of chemical compounds ormedicinal preparations (127) 127
acyclic, carbocyclic or heterocyclic compounds containingelements other than carbon, hydrogen, halogen, oxygen, nitrogen,sulfur, selenium or tellurium (96) 96
animals (62) 62
biochemistry & molecular biology (60) 60
humans (49) 49
structure-activity relationship (45) 45
testing (45) 45
investigating or analysing materials by determining theirchemical or physical properties (44) 44
measuring (44) 44
physics (44) 44
drug design (43) 43
amino acid sequence (32) 32
models, molecular (26) 26
chemistry, medicinal (25) 25
mice (25) 25
molecular sequence data (25) 25
index medicus (24) 24
enzyme inhibitors - pharmacology (19) 19
protein conformation (19) 19
binding (17) 17
biochemistry (17) 17
melanocyte-stimulating hormones - analogs & derivatives (16) 16
rats (16) 16
alpha-msh - analogs & derivatives (15) 15
binding sites (15) 15
phosphorylation (14) 14
rana pipiens (14) 14
c-src (13) 13
chemistry, organic (13) 13
melanocyte-stimulating hormones - pharmacology (13) 13
src (12) 12
src homology domains (12) 12
src-family kinases - antagonists & inhibitors (12) 12
beer (11) 11
crystallography, x-ray (11) 11
design (11) 11
doors, windows, shutters, or roller blinds in general (11) 11
enzyme inhibitors - chemistry (11) 11
enzymology (11) 11
fixed constructions (11) 11
ladders (11) 11
microbiology (11) 11
mutation or genetic engineering (11) 11
spirits (11) 11
tyrosine kinase (11) 11
vinegar (11) 11
wine (11) 11
biological assay (10) 10
enzyme inhibitors - chemical synthesis (10) 10
inhibitors (10) 10
ligands (10) 10
lizards (10) 10
pharmacology & pharmacy (10) 10
phosphotyrosine (10) 10
skin - drug effects (10) 10
activation (9) 9
acyclic or carbocyclic compounds (9) 9
expression (9) 9
molecular structure (9) 9
protein binding (9) 9
proteins (9) 9
receptors (9) 9
chronic myeloid-leukemia (8) 8
crystal-structure (8) 8
fixed or movable closures for openings in buildings, vehicles,fences or like enclosures in general, e.g. doors, windows,blinds, gates (8) 8
imatinib (8) 8
inhibitory concentration 50 (8) 8
peptide (8) 8
protein kinase inhibitors - pharmacology (8) 8
adenosine triphosphate - analogs & derivatives (7) 7
alpha-msh - pharmacology (7) 7
analysis (7) 7
antineoplastic agents - pharmacology (7) 7
biochemical research methods (7) 7
cell line, tumor (7) 7
female (7) 7
general tagging of cross-sectional technologies spanning over several sections of the ipc (7) 7
general tagging of new technological developments (7) 7
multidisciplinary sciences (7) 7
oligopeptides - pharmacology (7) 7
peptides - chemistry (7) 7
signal-transduction (7) 7
substrate specificity (7) 7
technical subjects covered by former uspc cross-reference art collections [xracs] and digests (7) 7
tyrosine (7) 7
adenylyl cyclases - metabolism (6) 6
amino-acids (6) 6
analogs (6) 6
bone resorption - drug therapy (6) 6
cancer (6) 6
compositions thereof (6) 6
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (529) 529
French (119) 119
German (55) 55
Chinese (18) 18
Portuguese (10) 10
Spanish (8) 8
Japanese (7) 7
Danish (3) 3
Korean (2) 2
Finnish (1) 1
Greek (1) 1
Norwegian (1) 1
Russian (1) 1
Slovenian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Proceedings of the National Academy of Sciences, ISSN 0027-8424, 09/2013, Volume 110, Issue 36, pp. E3445 - E3454
Journal Article
Chemical Biology & Drug Design, ISSN 1747-0277, 12/2011, Volume 78, Issue 6, pp. 907 - 908
Journal Article
RSC Drug Discovery Series, ISSN 2041-3203, 2015, Volume 2015-, Issue 40, pp. 339 - 366
Journal Article
ISSN 2041-6520, 5/2019, Volume 1, Issue 19, pp. 573 - 578
Ni/photoredox (4DPAIPN) dual catalysis enabled challenging peptide C(sp 2 )-O coupling reactions. Successful cross-coupling reactions were demonstrated with... 
Journal Article
1998, Pharmaceutical biotechnology, ISBN 0306457431, Volume 11
eBook
Chemical Biology & Drug Design, ISSN 1747-0277, 12/2011, Volume 78, Issue 6, pp. 907 - 908
Journal Article
Chemical Biology and Drug Design, ISSN 1747-0277, 12/2009, Volume 74, Issue 6, pp. 525 - 526
Journal Article
Chemical Biology and Drug Design, ISSN 1747-0277, 01/2010, Volume 75, Issue 1, pp. 1 - 2
Journal Article
CHEMICAL BIOLOGY & DRUG DESIGN, ISSN 1747-0277, 04/2010, Volume 75, Issue 4, pp. 348 - 359
Journal Article
Chemical Biology and Drug Design, ISSN 1747-0277, 12/2010, Volume 76, Issue 6, pp. 459 - 459
Journal Article
Nature Chemical Biology, ISSN 1552-4450, 2006, Volume 2, Issue 12, pp. 646 - 648
By building on the successes of the past and leveraging both innovative technologies and predictive knowledge, scientists can develop smarter ways to create a... 
MUTANTS | ABL INHIBITORS | BIOCHEMISTRY & MOLECULAR BIOLOGY | BCR-ABL | IMATINIB | RESISTANCE | GENOME | KINASE DOMAIN | MOLECULES | STRATEGIES | PROTEOMICS | Models, Molecular | Drug Industry - organization & administration | Drug Design | Research & development | R&D | Biochemistry | Biomedical research | Pharmaceutical industry | Technological change
Journal Article
Cancer Cell, ISSN 1535-6108, 2009, Volume 16, Issue 5, pp. 401 - 412
Inhibition of BCR-ABL by imatinib induces durable responses in many patients with chronic myeloid leukemia (CML), but resistance attributable to kinase domain... 
CHEMBIO | HUMDISEASE | CHRONIC MYELOGENOUS LEUKEMIA | DASATINIB BMS-354825 | MESYLATE | CML | ONCOLOGY | KINASE DOMAIN MUTATIONS | AMN107 | IMATINIB RESISTANCE | NILOTINIB | Proto-Oncogene Proteins c-abl - antagonists & inhibitors | Humans | Imidazoles - chemistry | Leukemia, Myelogenous, Chronic, BCR-ABL Positive - drug therapy | Leukemia, Myelogenous, Chronic, BCR-ABL Positive - genetics | Crystallography, X-Ray | Pyridazines - pharmacology | Protein Kinase Inhibitors - chemistry | Leukemia, Myelogenous, Chronic, BCR-ABL Positive - pathology | Antineoplastic Agents - pharmacology | Fusion Proteins, bcr-abl - chemistry | Leukemia, Myelogenous, Chronic, BCR-ABL Positive - enzymology | Proto-Oncogene Proteins c-abl - genetics | Cell Growth Processes - drug effects | Proto-Oncogene Proteins c-abl - chemistry | Models, Molecular | Imidazoles - pharmacology | Antineoplastic Agents - chemistry | Mice, SCID | Pyridazines - chemistry | Fusion Proteins, bcr-abl - genetics | Animals | Signal Transduction - drug effects | Fusion Proteins, bcr-abl - antagonists & inhibitors | Cell Line, Tumor | Proto-Oncogene Proteins c-abl - metabolism | Mice | Protein Kinase Inhibitors - pharmacology | Fusion Proteins, bcr-abl - metabolism | Chronic myeloid leukemia | BCR protein | Imatinib | Mutagenesis | Abl protein | Mutation | Fusion protein | Tumors | Index Medicus | imatinib resistance | dasatinib | nilotinib | compound mutation
Journal Article
Chemical Biology & Drug Design, ISSN 1747-0277, 12/2009, Volume 74, Issue 6, pp. 525 - 526
Journal Article
Chemical Biology & Drug Design, ISSN 1747-0277, 12/2007, Volume 70, Issue 6, pp. 473 - 474
Journal Article
Chemical Biology & Drug Design, ISSN 1747-0277, 12/2007, Volume 70, Issue 6, pp. 473 - 474
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.